Savara Inc. (SVRA)
NASDAQ·Healthcare·Biotechnology
$5.30
-0.56%
Mkt Cap $1.16B
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+88.7%
Consensus $10.00 vs current $5.30
NASDAQ·Healthcare·Biotechnology
$5.30
-0.56%
Mkt Cap $1.16B
No recent rating data.
Price Target (11 analysts)
$10.00
Range $10.00 – $10.00
+88.7%
Consensus $10.00 vs current $5.30